{
    "clinical_study": {
        "@rank": "72265", 
        "acronym": "PATHOQUEST1", 
        "arm_group": {
            "arm_group_label": "No study treatment"
        }, 
        "biospec_descr": {
            "textblock": "DNA sample by patient"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The study patients are patients suffering from primary or secondary immunodeficiencies\n      investigated in the Hospital Necker for a suspected infectious disease.\n\n      The study purpose is to assess the performance of a High Throughput Sequencing method, the\n      PATHOQUEST method (from sample preparation to bio informatic analysis), versus the classic\n      diagnostic approach.\n\n      The study will evaluate the capacity of the PATHOQUEST method to detect pathogens\n      responsible for an infectious disease episode and will also evaluate the delay of obtention\n      of results compared to the classic diagnostic approach."
        }, 
        "brief_title": "Evaluation of High Throughput Sequencing for Screening of Pathogens in Immunocompromised Patients With Suspected Infectious Disease.", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Immunodeficiency and Suspected Infection", 
        "condition_browse": {
            "mesh_term": [
                "Communicable Diseases", 
                "Infection", 
                "Immunologic Deficiency Syndromes"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Summary of inclusion criteria:\n\n          1. Primary or secondary immunodeficiencies defined by\n\n               -  Solid organ transplantation and immunosuppressive drug\n\n               -  Recent chemotherapy\n\n               -  Hematopo\u00efetic Stem Cells transplantation\n\n               -  Primary immune deficiency\n\n               -  Auto-immune disease\n\n               -  HIV infection\n\n          2. Infection suspicion\n\n          3. Microbiological investigation\n\n          4. Adult or child above 1 year\n\n          5. Hospitalization at Necker-Enfants malades hospital\n\n          6. Registration to Healthcare organism\n\n          7. ICF signature\n\n        Summary of exclusion criteria:\n\n          1. Obvious diagnosis following clinical examination\n\n          2. Participation in a clinical trial for a new drug\n\n          3. People under legal guardianship\n\n          4. People unable to fulfil the required medical follow-up"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "1 Year", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Immunocompromised patients hospitalized for a suspected infectious disease"
            }
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02007642", 
            "org_study_id": "PTQCT01-2013"
        }, 
        "intervention": {
            "arm_group_label": "No study treatment", 
            "description": "During the hospitalization of the patient, when a sampling is done for classic follow-up and diagnosis, additionnal blood sampling will be done, for the PATHOQUEST method.\nOther body fluids might be taken (if the sampling is done for the classic follow-up), such as cerebrospinal fluid, ascite...", 
            "intervention_name": "Blood sampling / Body fluid sampling", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 5, 2013", 
        "location": {
            "contact": {
                "email": "marc.lecuit@nck.aphp.fr", 
                "last_name": "Marc LECUIT, Pr"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "state": "Ile de France", 
                    "zip": "75015"
                }, 
                "name": "Hopital Necker - Enfants malades"
            }, 
            "investigator": {
                "last_name": "Marc LECUIT, Pr", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "Performance Assessment of High Throughput Sequencing for the Detection of Pathogens in Immunocompromised Patients With Suspected Infectious Disease.", 
        "overall_official": {
            "affiliation": "Pathoquest", 
            "last_name": "Marc ELOIT, Pr", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome will assess the number of diagnostics obtained by the  PATHOQUEST method and classic diagnostic approach.", 
            "measure": "Identification of pathogens responsible for the infection", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02007642"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The delay of obtention of results will be compared to determine which approach allows an earlier diagnosis.", 
                "measure": "Delay of obtention of diagnostic", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Comparison of the cost of the classic diagnostic approach and PATHOQUEST method, including cost of the hospital stay, microbiological tests performed, empirical anti-infectious drugs prescribed.", 
                "measure": "Economic impact of the PATHOQUEST method", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "source": "Pathoquest", 
        "sponsors": {
            "collaborator": {
                "agency": "Imagine - Institute of Genetic Diseases", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Pathoquest", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}